Search

Your search keyword '"Fukaya, Hidehira"' showing total 10 results
Start Over Author "Fukaya, Hidehira" Journal heart and vessels
10 results on '"Fukaya, Hidehira"'

3. Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry

Author

Usuda, Keisuke, Kato, Takeshi, Tsuda, Toyonobu, Tada, Hayato, Niwa, Satoru, Usui, Soichiro, Sakata, Kenji, Hayashi, Kenshi, Furusho, Hiroshi, Kawashiri, Masaaki, Takamura, Masayuki, Otsuka, Takayuki, Suzuki, Shinya, Hirata, Akio, Murakami, Masato, Takami, Mitsuru, Kimura, Masaomi, Fukaya, Hidehira, Nakahara, Shiro, Shimizu, Wataru, Iwasaki, Yu-ki, Hayashi, Hiroshi, Harada, Tomoo, Nakajima, Ikutaro, Okumura, Ken, Koyama, Junjiroh, Tokuda, Michifumi, Yamane, Teiichi, Momiyama, Yukihiko, Tanimoto, Kojiro, Soejima, Kyoko, Nonoguchi, Noriko, Ejima, Koichiro, Hagiwara, Nobuhisa, Harada, Masahide, Sonoda, Kazumasa, Inoue, Masaru, Kumagai, Koji, Hayashi, Hidemori, Satomi, Kazuhiro, Yazaki, Yoshinao, Watari, Yuji, Arai, Masaru, Watanabe, Ryuta, Yokoyama, Katsuaki, Matsumoto, Naoya, Nagashima, Koichi, and Okumura, Yasuo

Published
2022
Full Text
View/download PDF

7. Fibrillation cycle length predicts cardiovascular events in patients with long-standing persistent atrial fibrillation

Author

Nakamura, Hironori, primary, Niwano, Shinichi, additional, Fukaya, Hidehira, additional, Kishihara, Jun, additional, Satoh, Akira, additional, Oikawa, Jun, additional, Yoshizawa, Tomoharu, additional, Ishizue, Naruya, additional, Igarashi, Tazuru, additional, Fujiishi, Tamami, additional, Nishinarita, Ryo, additional, Horiguchi, Ai, additional, and Ako, Junya, additional

Published
2021
Full Text
View/download PDF

8. Reduced atrial conduction velocity is associated with the recurrence of atrial fibrillation after catheter ablation

Author

Sato, Tetsuro, primary, Fukaya, Hidehira, additional, Oikawa, Jun, additional, Saito, Daiki, additional, Matsuura, Gen, additional, Arakawa, Yuki, additional, Kobayashi, Shuhei, additional, Shirakawa, Yuki, additional, Nishinarita, Ryo, additional, Horiguchi, Ai, additional, Ishizue, Naruya, additional, Kishihara, Jun, additional, Niwano, Shinichi, additional, and Ako, Junya, additional

Published
2021
Full Text
View/download PDF

10. Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry.

Author

Iso K, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, and Okumura Y

Subjects
Aged, Atrial Fibrillation complications, Female, Follow-Up Studies, Humans, Incidence, Japan epidemiology, Male, Middle Aged, Recurrence, Risk Factors, Stroke epidemiology, Stroke etiology, Time Factors, Treatment Outcome, Anticoagulants therapeutic use, Atrial Fibrillation therapy, Catheter Ablation methods, Propensity Score, Registries, Risk Assessment methods, Stroke prevention & control
Abstract

Whether ablation for atrial fibrillation (AF) is, in terms of clinical outcomes, beneficial for Japanese patients has not been clarified. Drawing data from 2 Japanese AF registries (AF Frontier Ablation Registry and SAKURA AF Registry), we compared the incidence of clinically relevant events (CREs), including stroke/transient ischemic attack (TIA), major bleeding, cardiovascular events, and death, between patients who underwent ablation (n = 3451) and those who did not (n = 2930). We also compared propensity-score matched patients (n = 1414 in each group). In propensity-scored patients who underwent ablation and those who did not, mean follow-up times were 27.2 and 35.8 months, respectively. Annualized rates for stroke/TIA (1.04 vs. 1.06%), major bleeding (1.44 vs. 1.20%), cardiovascular events (2.15 vs. 2.49%) were similar (P = 0.96, 0.39, and 0.35, respectively), but annualized death rates were lower in the ablation group than in the non-ablation group (0.75 vs.1.28%, P = 0.028). After multivariate adjustment, the risk of CREs was statistically equivalent between the ablation and non-ablation groups (hazard ratio [HR] 0.89, 95% confidence interval [CI] 0.71-1.11), but it was significantly low among patients who underwent ablation for paroxysmal AF (HR 0.68 [vs. persistent AF], 95% CI 0.49-0.94) and had a CHA 2 DS 2 -VASc score  < 3 (HR 0.66 [vs. CHA 2 DS 2 -VASc score ≥ 3], 95% CI 0.43-0.98]). The 2-year risk reduction achieved by ablation may be small among Japanese patients, but AF ablation may benefit those with paroxysmal AF and a CHA 2 DS 2 -VASc score < 3.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results